The pharmaceutical sector has been exempted from Trump's tariffs, providing temporary relief for companies like Pfizer and Johnson & Johnson. However, concerns remain about potential future tariffs, especially for EU countries like Ireland, which heavily rely on US pharmaceutical exports. The EU is preparing for possible investigations into the pharmaceutical sector, emphasizing its strategic importance. The long-term impact of current trade disputes may not be felt for several years, particularly in Ireland and Belgium, where the pharmaceutical industry plays a crucial role in the economy. Article complet (Euronews.com)